Other groups showed that compared with normal brain tissue, the protein and mRNA levels of RGC32 are low in several glioma cell lines, including T98G, U251, U373, and U87 (Fernandez-Aroca et al., 2019). This evidence concerns the gene RGCC and central nervous system cancer.